A near-autonomous AI chemist improves a challenging reaction in medicinal chemistry
OpenAI and Molecule.one used a near-autonomous GPT-5.4 AI chemist to improve a key medicinal chemistry reaction.
OpenAI partnered with Molecule.one to demonstrate a near-autonomous AI chemist powered by GPT-5.4 that improved a challenging drug-making reaction. It signals continued progress in applying frontier models as autonomous agents in scientific R&D, a high-value domain for AI deployment.